We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (SJATRT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02114229
Recruitment Status : Recruiting
First Posted : April 15, 2014
Last Update Posted : March 9, 2018
Millennium Pharmaceuticals, Inc.
Takeda Pharmaceuticals U.S.A., Inc.
Information provided by (Responsible Party):
St. Jude Children's Research Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2023
  Estimated Study Completion Date : May 2027